Abstract
The Covid-19 pandemic caused by SARS-CoV-19. Due to insufficiency of targeted medication, enforced scientist to form new antiviral drug. We describe our current understanding of Phycocyanobilin, Vidarabine, Avarol, and Mycalamide A, a marine bioactive molecule that having good binding affinity with covid-19 receptor. We perform molecular docking study by using Schrödinger software (maestro v 10.2) for SARS CoV-2 receptor spike protein complexed with neutralizing antibody CT-P59(PDB ID-7CM4) and SARS CoV-2 receptor in complexed with antibody ION-300(PDB ID-7BNV) with marine bioactive compound collected from Pub-chem. database. According to our findings, these compounds have good receptor binding affinity, with Phycocyanobilin and Vidarabine having the highest binding affinity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
